{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:49Z","timestamp":1793126029316,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["735-63251017"],"award-info":[{"award-number":["735-63251017"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B20016"],"award-info":[{"award-number":["B20016"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107664","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:11:37Z","timestamp":1789427497000},"page":"107664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pirfenidone lung distribution amplified in idiopathic pulmonary fibrosis: Roles of tight junction disruption and drug transporter dysregulation"],"prefix":"10.1016","volume":"227","author":[{"given":"Xiaoting","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conglu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueren","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouchun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107664_bib0001","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-025-05243-w","article-title":"Chloride channels and mast cell function: pioneering new frontiers in IBD therapy","author":"Aljameeli","year":"2025","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.ejps.2026.107664_bib0002","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1055\/s-0039-1694021","article-title":"Cystic fibrosis: pathophysiology of lung disease","volume":"40","author":"Bergeron","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.ejps.2026.107664_bib0003","first-page":"201","article-title":"Optimization of modeling method for pulmonary fibrosis rat model","volume":"31","author":"Chen","year":"2023","journal-title":"Acta Lab. Anim. Sci. Sin."},{"issue":"3","key":"10.1016\/j.ejps.2026.107664_bib0004","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/cells9030775","article-title":"Pirfenidone inhibits cell proliferation and collagen i production of primary human intestinal fibroblasts","volume":"9","author":"Cui","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ejps.2026.107664_bib0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1211\/jpp.61.05.0006","article-title":"RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models","volume":"61","author":"Endter","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2026.107664_bib0006","first-page":"326","article-title":"Acute respiratory distress syndrome: new definition, current and future therapeutic options","volume":"5","author":"Fanelli","year":"2013","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejps.2026.107664_bib0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.fct.2017.12.034","article-title":"Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression","volume":"112","author":"Fateme","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.ejps.2026.107664_bib0009","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s10753-022-01708-y","article-title":"Tight junctions, the epithelial barrier, and toll-like receptor-4 during lung injury","volume":"45","author":"Godbole","year":"2022","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.ejps.2026.107664_bib0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/ijms21020524","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and the emerging role of long non-coding RNAs","volume":"21","author":"Hadjicharalambous","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2026.107664_bib0011","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","article-title":"An official American thoracic society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis","volume":"56","author":"Jenkins","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejps.2026.107664_bib0012","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12931-019-1093-z","article-title":"Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-\u03b21","volume":"20","author":"Jin","year":"2019","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.ejps.2026.107664_bib0013","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15618","article-title":"Characterization of acute lung injury in the bleomycin rat model","volume":"11","author":"Kadam","year":"2023","journal-title":"Physiol. Rep."},{"issue":"6","key":"10.1016\/j.ejps.2026.107664_bib0014","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171301","article-title":"Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis","volume":"37","author":"Kasper","year":"2017","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.ejps.2026.107664_bib0015","doi-asserted-by":"crossref","first-page":"L185","DOI":"10.1152\/ajplung.00115.2016","article-title":"Alveolar epithelial disintegrity in pulmonary fibrosis","volume":"311","author":"Kulkarni","year":"2016","journal-title":"Am. J. Physiol. - Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.ejps.2026.107664_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0300-483X(01)00454-1","article-title":"Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters","volume":"167","author":"Leslie","year":"2001","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.ejps.2026.107664_bib0017","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5858\/arpa.2011-0511-OA","article-title":"Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis","volume":"136","author":"Leslie","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.ejps.2026.107664_bib0018","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1165\/rcmb.2013-0353OC","article-title":"Knockout mice reveal key roles for claudin 18 in alveolar barrier properties and fluid homeostasis","volume":"51","author":"Li","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.ejps.2026.107664_bib0019","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1111\/cas.15760","article-title":"SLC3A2 promotes tumor-associated macrophage polarization through metabolic reprogramming in lung cancer","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejps.2026.107664_bib0020","first-page":"1","article-title":"Introduction","volume":"15","author":"Mikio","year":"2010","journal-title":"Curr. Top. Membr."},{"issue":"1","key":"10.1016\/j.ejps.2026.107664_bib0021","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic mechanisms underlying idiopathic pulmonary fibrosis","volume":"17","author":"Moss","year":"2021","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"issue":"2","key":"10.1016\/j.ejps.2026.107664_bib0022","doi-asserted-by":"crossref","first-page":"L193","DOI":"10.1152\/ajplung.00349.2010","article-title":"Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis","volume":"302","author":"Ohta","year":"2012","journal-title":"Am. J. Physiol. - Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejps.2026.107664_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115712","article-title":"Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study","volume":"168","author":"Poo","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.ejps.2026.107664_bib0024","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1165\/rcmb.2013-0541RT","article-title":"Breaking barriers. new insights into airway epithelial barrier function in health and disease","volume":"50","author":"Rezaee","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejps.2026.107664_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-0716-1554-6_8","article-title":"The structure and mechanism of drug transporters","volume":"2342","author":"Roberts","year":"2021","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.ejps.2026.107664_bib0026","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1091\/mbc.11.12.4131","article-title":"Complex phenotype of mice lacking occludin, a component of tight junction strands","volume":"11","author":"Saitou","year":"2000","journal-title":"Mol. Biol. Cell"},{"issue":"9","key":"10.1016\/j.ejps.2026.107664_bib0027","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/jps.24381","volume":"104","author":"Sakamoto","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2026.107664_bib0028","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00795-003-0219-y","article-title":"Tight junctions and human diseases","volume":"36","author":"Sawada","year":"2003","journal-title":"Med. Electron Microsc."},{"issue":"08","key":"10.1016\/j.ejps.2026.107664_bib0029","first-page":"828","article-title":"Perinatal reduced blood concentrations of free carnitine and acylcarnitines in infants with cystic fibrosis","volume":"38","author":"Schulpis","year":"2019","journal-title":"Am. J. Perinatol."},{"issue":"23","key":"10.1016\/j.ejps.2026.107664_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239168","article-title":"Organic cation transporters in the lung\u2014current and emerging (patho)physiological and pharmacological concepts","volume":"21","author":"Selo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2026.107664_bib0031","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"issue":"2","key":"10.1016\/j.ejps.2026.107664_bib0032","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00418-015-1382-7","article-title":"Pharmacokinetic and pharmacometabolomic study of pirfenidone in normal mouse tissues using high mass resolution MALDI-FTICR-mass spectrometry imaging","volume":"145","author":"Sun","year":"2015","journal-title":"Histochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejps.2026.107664_bib0033","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2018.01.027","article-title":"Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-\u03b21\/Smad\/CTGF signaling pathway","volume":"822","author":"Sun","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejps.2026.107664_bib0034","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.3390\/v7092865","article-title":"Tight junctions go viral!","volume":"7","author":"Torres","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ejps.2026.107664_bib0036","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semcdb.2014.08.011","article-title":"Architecture of tight junctions and principles of molecular composition","volume":"36","author":"Van","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ejps.2026.107664_bib0035","first-page":"469","article-title":"Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells","volume":"3","author":"Van der Deen","year":"2008","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"2","key":"10.1016\/j.ejps.2026.107664_bib0037","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41419-020-2329-z","article-title":"Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206+ M2-like macrophage polarization","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ejps.2026.107664_bib0038","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00424-016-1917-3","article-title":"Tight junctions in pulmonary epithelia during lung inflammation","volume":"469","author":"Wittekindt","year":"2016","journal-title":"Pfl\u00fcg. Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.ejps.2026.107664_bib0039","doi-asserted-by":"crossref","unstructured":"You, G., & Morris, M. E. (2014). Overview of drug transporter families 1\u20137.","DOI":"10.1002\/9781118705308.ch1"},{"issue":"08","key":"10.1016\/j.ejps.2026.107664_bib0040","first-page":"705","article-title":"Progress in the study of drug transporters in lung cells","volume":"30","author":"Zhang","year":"2021","journal-title":"Chin. J. New Drugs"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:51:55Z","timestamp":1793123515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S0928098726002381"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107664","relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.175205908.83832169\/v1","asserted-by":"object"}]},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pirfenidone lung distribution amplified in idiopathic pulmonary fibrosis: Roles of tight junction disruption and drug transporter dysregulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107664"}}